We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Prioritizes Review of COVID-19 Diagnostic Tests from ‘Experienced Developers’
FDA Prioritizes Review of COVID-19 Diagnostic Tests from ‘Experienced Developers’
The FDA is now prioritizing its review of Emergency Use Authorization (EUA) requests on a smaller subset of experienced developers applying for tests that are likely to have either a significant public health benefit or fulfill an unmet need, according to final guidance released by the agency Tuesday.